Advertisement
Advertisement
MLTX
MoonLake Immunotherapeutics Class A Ordinary Shares
18.41
USDSponsored
+0.22
+1.21%
May 13, 16:00 UTC -4
Closed
Pre-Market
18.36
-0.05
-0.27%
MoonLake Immunotherapeutics Class A Ordinary Shares Financial Snapshot
| Market Cap | 1.35B |
| Beta | 1.19 |
| Earnings Per Share (EPS) | -3.52 |
| Price-to-Book (P/B) Ratio | 4.55 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 24.34% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -66.56% |
| Current Ratio | 9.27% |
| Free Cash Flow | -196.04M |
Trending Stocks
Advertisement